Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma

This study investigated how differences in drug distribution and free fraction at different tumor and tissue sites influence the efficacy of the multikinase inhibitor ponatinib in a patient-derived xenograft model of glioblastoma (GBM). Efficacy studies in GBM6 flank (heterotopic) and intracranial (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pharmacol Exp Ther
Main Authors: Laramy, Janice K., Kim, Minjee, Gupta, Shiv K., Parrish, Karen E., Zhang, Shuangling, Bakken, Katrina K., Carlson, Brett L., Mladek, Ann C., Ma, Daniel J., Sarkaria, Jann N., Elmquist, William F.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2017
Assuntos:
Drug Discovery and Translational Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625285/
https://ncbi.nlm.nih.gov/pubmed/28847917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.243477
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares